SCHEMBL31539990

SCHEMBL31539990

CCNc1ccccc1Oc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
L3MBTL1 Q9Y468 4/20 0.53
POLB P06746 2/20 0.53
ATM Q13315 1/20 0.53
CACNA1B Q00975 3/20 0.50
ADRA2C P18825 1/20 0.50
GAA P10253 2/20 0.49
LMNA P02545 2/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.45
RIPK1 Q13546 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
LTA4H P09960 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12691945 1.00 TSHR (0.53) TSHRL3MBTL1POLBATMCACNA1B
SCHEMBL5606439 0.85 L3MBTL1 (0.54) TSHRL3MBTL1POLBATMCACNA1B
SCHEMBL11639599 0.80 L3MBTL1 (0.56) TSHRL3MBTL1POLBATMCACNA1B
SCHEMBL11215406 0.79 CACNA1B (0.63) TSHRL3MBTL1CACNA1BADRA2CGAA
SCHEMBL1341786 0.78 TSHR (0.58) TSHRL3MBTL1POLBATMCACNA1B
SCHEMBL30994802 0.78 CHRM2 (0.58) L3MBTL1POLBGAAALDH1A1MAPT
SCHEMBL1022424 0.78 CHRM2 (0.58) L3MBTL1POLBGAAALDH1A1MAPT
SCHEMBL13067611 0.77 HTR2A (0.56) L3MBTL1CACNA1BLMNAMAPTSMN1; SMN2
SCHEMBL10870072 0.77 TSHR (0.62) TSHRL3MBTL1POLBATMADRA2C
SCHEMBL7835963 0.77 ADRA2C (0.58) TSHRL3MBTL1POLBATMADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281180-B2 Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same NEW YORK UNIVERSITY (US) 2025-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12281180-B2 Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same WNT1, WNT3, WNT3A TSHR 3550/4885L3MBTL1 2508/4885POLB 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.